IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 165 filers reported holding IMPAX LABORATORIES INC in Q4 2013. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $5,396,000 | -51.7% | 277,414 | -58.6% | 0.02% | -34.3% |
| Q4 2017 | $11,165,000 | +13.0% | 670,582 | +37.8% | 0.04% | -10.3% |
| Q3 2017 | $9,880,000 | -41.6% | 486,691 | -53.7% | 0.04% | -44.3% |
| Q2 2017 | $16,929,000 | +482.6% | 1,051,484 | +357.7% | 0.07% | +400.0% |
| Q1 2017 | $2,906,000 | +1353.0% | 229,750 | +3576.0% | 0.01% | +1300.0% |
| Q1 2016 | $200,000 | -90.5% | 6,250 | -92.5% | 0.00% | -96.3% |
| Q4 2013 | $2,098,000 | – | 83,438 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $98,362,000 | 8.33% |
| Krensavage Asset Management, LLC | 587,882 | $18,824,000 | 6.75% |
| Hound Partners | 6,757,558 | $216,377,000 | 5.88% |
| Asymmetry Capital Management, L.P. | 62,050 | $1,987,000 | 5.18% |
| Orbimed Advisors | 6,776,100 | $216,971,000 | 2.28% |
| Pennant Capital Management, LLC | 2,083,074 | $66,700,000 | 1.90% |
| UNIVERSITY OF NOTRE DAME DU LAC | 41,104 | $1,316,000 | 1.62% |
| Tygh Capital Management, Inc. | 137,975 | $4,418,000 | 1.29% |
| JW Asset Management, LLC | 53,373 | $1,709,000 | 1.12% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,784 | $8,863,000 | 0.93% |